Substrate specificity of YqfB and D8_RL amidohydrolases. by Viktorija Preitakaitė (17508980)

MTT assay of the HCT116 cell lines expressing YqfB or D8_RL after exposure to 10 μM of prodrugs. by Viktorija Preitakaitė (17508980)

Data_Sheet_1_miR482f and miR482c-5p from edible plant-derived foods inhibit the expression of pro-inflammatory genes in human THP-1 macrophages.docx by Ester Díez-Sainz (17485836)

“…Transfections with miR482f and miR482c-5p mimics decreased the gene expression of CLEC7A and NFAM1, and TRL6, respectively, in human THP-1 monocytes differentiated to macrophages, which had an impact on gene expression profile of inflammatory biomarkers. …”

S1 Data - by Sinthia Kabir Mumu (17705902)

“…The result is substantiated by significant decrease in blood glucose level in prevention (29.5 mg/dL; <i>p</i> = 0.002) and treatment (31.5 mg/dL; <i>p</i> = 0.006) groups, compared to stress group (47.33 mg/dL) at the end of the experiment. …”

S2 Data - by Sinthia Kabir Mumu (17705902)

“…The result is substantiated by significant decrease in blood glucose level in prevention (29.5 mg/dL; <i>p</i> = 0.002) and treatment (31.5 mg/dL; <i>p</i> = 0.006) groups, compared to stress group (47.33 mg/dL) at the end of the experiment. …”

Inhibition of sphingosine kinase synergizes with ABT-263 to kill leukemia cells by causing accumulation of ceramide and sphingosine while decreasing glucosylceramide and S1P. by Lavona Casson (288527)

Image_5_Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice.jpg by Antonietta Vilella (6860801)

The <i>Listeria</i> Small RNA Rli27 Regulates a Cell Wall Protein inside Eukaryotic Cells by Targeting a Long 5′-UTR Variant by Juan J. Quereda (651911)

“…The 234-nucleotide 5′-UTR is also the target of a small RNA (sRNA) denoted Rli27, which we identified by bioinformatics analysis as having extensive base pairing potential with the long 5′-UTR. …”

Clinical evolution at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

SaFi, laboratory, radiology, vaccine status, and inpatient treatment data. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Adverse pregnancy outcomes recorded among study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Probability of medical discharge at 60 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Quality of Antenatal care and adverse maternal and fetal outcomes. by Seth Amponsah-Tabi (13949142)

Subjects:

Distribution of different levels of quality of antenatal care provided to study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Sociodemographic and reproductive factors associated with good quality antenatal care. by Seth Amponsah-Tabi (13949142)

Subjects:

Sociodemographic and reproductive characteristics of the study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Comorbidities and severity scales at admission for the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

S1 Data - by Seth Amponsah-Tabi (13949142)

Subjects:

Probability of remaining as an inpatient at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Probability of medical discharge at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects: